COVID-19 and smoking: A systematic review of the evidence

Tobacco Induced Diseases

Volumn 18, Issue March, 2020, Pages

  Vardavas, Constantine I ^a,b   Nikitara, Katerina ^b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Coronavirus; COVID 19; Smoking; Tobacco

Indexed keywords

ARTIFICIAL VENTILATION; CHINA; CLINICAL OUTCOME; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EX-SMOKER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MORTALITY; MORTALITY RISK; PRIORITY JOURNAL; REVIEW; SMOKING; SURVIVOR; SYSTEMATIC REVIEW;

EID: 85083053688     PISSN: None     EISSN: 16179625     Source Type: Journal    
DOI: 10.18332/tid/119324     Document Type: Review

References (13)

1. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689-697. doi:10.1016/S0140-6736(20)30260-9.
2. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. doi:10.1056/NEJMoa2001316
3. ECDC. Situation update worldwide, as of March 19 2020. https://www.ecdc.europa.eu/en/geographicaldistribution-2019-ncov-cases. Accessed March 19, 2020.
4. Khot WY, Nadkar MY. The 2019 Novel Coronavirus Outbreak-A Global Threat. J Assoc Physicians India. 2020;68(3):67. PMID: 32138488
5. Tonnesen P, Marott JL, Nordestgaard B, Bojesen SE, Lange P. Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study. Tob Induc Dis. 2019;17(October). doi:10.18332/tid/112459
6. Zhou Z, Chen P, Peng H. Are healthy smokers really healthy? Tob Induc Dis. 2016;14(November). doi:10.1186/s12971-016-0101-z
7. Park JE, Jung S, Kim A. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18(1):574. doi:10.1186/s12889-018-5484-8
8. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164(20):2206-2216. doi:10.1001/archinte.164.20.2206
9. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. doi:10.1016/S0140-6736(20)30566-3
10. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020. doi:10.1111/all.14238
11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
12. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. doi:10.1056/NEJMoa2002032
13. Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalised patients with 2019 novel coronavirus disease. Chin Med J. 2020. doi:10.1097/CM9.0000000000000775